Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Corcept Therapeutics Incorporated
EIR
•Corcept Therapeutics Incorporated•October 19, 2020

Corcept Therapeutics Incorporated – FDA EIR, Oct 19, 2020

Record Details

An FDA inspection of Corcept Therapeutics Incorporated was conducted from October 14 to October 19, 2020, at their Menlo Park, CA facility. The inspection was a focused review of the company's postmarket surveillance and reporting procedures for its only approved drug product, Korlym (mifepristone), which is used for controlling hyperglycemia in patients with Cushing's Syndrome. The regulatory framework for this inspection specifically targeted compliance with Postmarket Adverse Drug Event (PADE) reporting requirements under NDA 202107. The FDA investigator reviewed the company's established procedures for PADE evaluation and reporting, including product complaint files and randomly selected complaint forms. The inspection also covered the firm's pharmacovigilance subcontractors and electronic data systems used for safety and complaint management. Additionally, two postmarket clinical studies related to Korlym were examined. Crucially, the inspection concluded without any observations of objectionable conditions. The FDA investigator did not issue an FDA Form 483 (Inspectional Observations), indicating full compliance with the inspected areas. Consequently, no specific violations or required actions were noted during this inspection, reflecting an effective adverse drug event reporting system at Corcept Therapeutics.

Company
Corcept Therapeutics Incorporated
Inspection date
October 19, 2020
Product type
drugs
Office
Los Angeles District Office
Person
  • Thea C. Grome (investigator)
View Company Profile

ID · 091c22e1-723e-4553-92ad-938fdb56795d

Violation Codes1
21 CFR 312

Full citation text and observation details available on the Dashboard.

Other documents for Corcept Therapeutics Incorporated
  • 483 - 2014-05-09May 9, 2014

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Corcept Therapeutics Incorporated
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.